A multi-authored, clinical work describing controversies in the management of ovarian cancer, and offering individual views and recommendations of the experts followed by commentary from the editors. The editors have chosen a panel format as a novel approach to assisting the reader.
FREE Two-Day Shipping for students on millions of items. Learn more |
Book Description
Editorial Reviews
From The New England Journal of Medicine
Of all the malignant conditions of the female genital system, ovarian cancer causes the most deaths. Unfortunately, little progress has been made in the fight against this cancer, although in the past few years the use of refined and more radical surgical techniques and adjuvant combination therapy have significantly improved survival. Response to initial therapy is the rule, but in the majority of patients progressive or recurrent disease develops after a rather short disease-free interval, usually one of only a few months.
There is a need for a book that furnishes physicians and scientists with new opportunities and refined strategies for clinical decision making and future research in ovarian cancer. Gershenson and McGuire have assembled more than 50 of the world's leading authorities to answer pertinent questions regarding controversies in the management of ovarian cancer. The editors have made their own contributions by including in each chapter a brief introduction and an editorial commentary concerning important new developments in the subject under discussion. Each section concludes with a summary and a reflection on the topics that pertain to the questions it set out to answer. The result is a comprehensive, well-balanced, and engaging treatise.
All the chapters begin with a brief description of the clinical or scientific aspects, or both, followed by the questions put to the authors. Particularly useful are the editors' stimulating commentaries based on open-minded discussions that address various aspects of the management of ovarian cancer, including prevention, early detection, and therapy. In addition to coverage of the conventional topics of surgical, radiotherapeutic, and chemotherapeutic interventions, chapters are included on screening, prophylactic oophorectomy, palliative care, quality of life, surveillance after the discontinuation of therapy, and the clinical relevance of basic research.
The book starts with the current status of screening for epithelial cancer, discusses various chemotherapy and radiotherapy protocols for early- and advanced-stage cancer as well as post-therapy surveillance, and then discusses the clinical application of basic-science investigations. Most important, promising new prognostic or stratification factors to be used in the design of randomized clinical trials are included. Testing of genetic markers, such as BRCA1, and new developments and future directions in gene therapy are also covered.
In actual clinical practice, a good decision results from the use of as much information as possible, including that which is controversial. The editors correctly state that controversy can be contentious and destructive and yet be healthy and illuminating as well. In designing their highly readable and forcefully communicated book, they asked each author to address very specific questions that were meant to resolve controversial issues. As a result, the design of the chapters is astute and every contribution is well referenced.
We found this excellent book to be a valuable source of novel, state-of-the-art information regarding the management of ovarian cancer. It will appeal to a broad spectrum of clinical investigators and basic scientists working in this field and gives the practicing physician a comparative assessment of various new approaches intended to improve the status of patients afflicted with ovarian cancer.
Reviewed by Manfred Schmitt, Ph.D., M.D.
Copyright © 1998 Massachusetts Medical Society. All rights reserved. The New England Journal of Medicine is a registered trademark of the MMS.
Product Details
Would you like to update product info or give feedback on images?
|
Customer Reviews
|
Share your thoughts with other customers:
|
||||||||||||||||||||||
|
Most Helpful Customer Reviews
10 of 10 people found the following review helpful:
5.0 out of 5 stars
Ovarian Cancer: Controversies in Management,
By Sandi Pniauskas (Ontario Canada) - See all my reviews
This review is from: Ovarian Cancer: Controversies in Management (Hardcover)
After having been diagnosed with Ovarian Cancer in 1999, I was anxious to obtain a copy. This book, I believe, is a must read for those newly diagnosed with Ovarian Cancer. While I had done a lot of research on my own and of course received advice from my Oncologists, I felt that this book put everything into perspective. It helped me to understand the basis of my Oncologists' recommendations. The contributors to the book are all leading international Gynecologic/Medical Oncologists, Radiation Oncologists, Pathologists - all those whose main interests lie in Ovarian/Gynecologic cancers. As medical technology and new information resulting from clinical trials become available, it would be helpful to have a Second Edition update sometime in the not so distant future.
Share your thoughts with other customers: Create your own review
|
|
Tag this product(What's this?)Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items. |
Sell a Digital Version of This Book in the Kindle Store
If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store.
Learn more
Customer Discussions
|
This product's forum
Active discussions in related forums
Search Customer Discussions
|
Related forums
|
